Skip to content

MRI HCG-Beta RIA Kit Cat. #MR-10100

by Microanalytic Research, Inc.

510(k) K801491

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK801491 Date13 Aug 1980ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
JHI
Device Class
Class II
Regulation
21 CFR Part 862.1155
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The MRI HCG-Beta RIA Kit Cat. #MR-10100 is an in vitro diagnostic radioimmunoassay (RIA) device designed for the quantitative measurement of human chorionic gonadotropin-beta (HCG-beta) in serum or plasma. It is classified as a Class II medical device and is intended for visual interpretation of pregnancy-related HCG levels, aiding in the detection of pregnancy or monitoring of certain gynecological conditions.

This kit is supplied as a single-use, non-sterile reagent system for laboratory use only. It is regulated under FDA 510(k) clearance (K801491) and falls under the product code JHI, with a regulatory classification of 862.1155. The device requires proper storage as specified in the accompanying instructions and is intended for use in clinical chemistry settings, adhering to standard laboratory protocols for RIA procedures.

Other devices from Microanalytic Research, Inc.

See all devices from Microanalytic Research, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical setting is this device intended for, and how is it typically used?

    This MRI HCG-Beta RIA Kit (Cat. #MR-10100) is designed for use in clinical chemistry laboratories. It is an in vitro diagnostic radioimmunoassay (RIA) device intended for the quantitative measurement of human chorionic gonadotropin-beta (HCG-beta) in serum or plasma samples. It aids in detecting pregnancy or monitoring gynecological conditions by visually interpreting HCG levels, following standard laboratory protocols for RIA procedures.

  • Is this device single-use or reusable, and what does that mean for its handling?

    The MRI HCG-Beta RIA Kit is supplied as a single-use, non-sterile reagent system. This means each kit is intended for one-time use only and should not be reused. Proper handling and disposal per laboratory protocols are required to ensure accuracy and prevent contamination.

  • What storage requirements should I follow for this kit?

    The MRI HCG-Beta RIA Kit requires proper storage as detailed in the accompanying instructions. While the data does not specify exact storage conditions (e.g., temperature or humidity), it is critical to follow the manufacturer’s guidelines to maintain the integrity of the reagents. Always store the kit in a way that prevents exposure to extreme temperatures, light, or contamination.

  • How is this device regulated, and what does that mean for its use in clinical practice?

    This device is regulated under the FDA’s 510(k) clearance pathway, with the clearance number K801491. It is classified as a Class II medical device under product code JHI and regulatory classification 862.1155. This means it has undergone a review by the FDA to demonstrate substantial equivalence to a predicate device, ensuring it meets safety and effectiveness standards for use in clinical chemistry settings. Its regulatory status confirms it is intended for prescription use and visual interpretation of HCG-beta levels.